$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Where can I buy Apellis? What's the price?
2025-10-19 11:44:20
Check Details
The overall response rate of ceritinib (Zanda) in the treatment of lung cancer can reach 72.5%_ Kanghule
2025-10-19 11:44:20
Check Details
Is ceritinib (Zanda) a new option after crizotinib resistance
2025-10-19 11:44:20
Check Details
Alectinib (Anshengsa) What are the advantages of alectinib in treating cancer?
2025-10-19 11:44:20
Check Details
What are the characteristics of DACOMITINIB compared with first-generation drugs?
2025-10-19 11:44:20
Check Details
Safety and effectiveness of crizotinib (Xalkori) in the treatment of advanced or metastatic ROS1-rearranged lung cancer
2025-10-19 11:44:20
Check Details
Efficacy data of Lorlatinib in the treatment of NSCLC patients carrying ALK/ROS1 rearrangements
2025-10-19 11:44:20
Check Details
Efficacy and safety of Lorlatinib
2025-10-19 11:44:20
Check Details
Comparison of clinical efficacy data between alectinib and crizotinib in the treatment of lung cancer?
2025-10-19 11:44:20
Check Details
How much does a box of the new anti-cancer drug lorlatinib cost? How much do you eat every day?
2025-10-19 11:44:20
Check Details
Dosage Selection for Patients Taking Capmatinib_Canghule
2025-10-19 11:44:20
Check Details
Safety and effectiveness of dacomitinib (Dozerun) in EGFR-positive advanced non-small cell lung cancer
2025-10-19 11:44:20
Check Details
1
2
...
3889
3890
3891
3892
3893
3894
3895
...
4163
4164
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
2
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
3
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
4
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
5
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
6
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
7
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
8
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
9
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
10
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
11
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
12
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data